TITLE: T32 Career Lunch
WHEN: January 30
DESCRIPTION:
Andrew Mazar, PhD
Chief Scientific Officer
and Director
Monopar Therapeutics
TITLE: T32 Career Lunch
WHEN: January 30
DESCRIPTION:
Andrew Mazar, PhD
Chief Scientific Officer
and Director
Monopar Therapeutics